Abingdon Health (LON:ABDX) Shares Down 7.2% – What’s Next?

Abingdon Health Plc (LON:ABDX)’s share price was down 7.2% on Tuesday . The stock traded as low as GBX 6 and last traded at GBX 6.27. Approximately 275,978 shares traded hands during mid-day trading, an increase of 101% from the average daily volume of 137,544 shares. The stock had previously closed at GBX 6.75.

Abingdon Health Trading Down 7.2%

The business has a fifty day moving average of GBX 6.77 and a 200-day moving average of GBX 6.43. The stock has a market capitalization of £15.73 million, a price-to-earnings ratio of -6.74 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96.

Abingdon Health (LON:ABDX) last issued its quarterly earnings results on Tuesday, November 11th. The company reported GBX (0.71) earnings per share for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.